Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Oct. 8, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 8, 2013

Acorda, Alkermes, Alnylam, Cornerstone, Eleison, and Keryx

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical
Alnylam advances ALAS-1 attacker . . . read more

Phase I
Acorda begins second HF trial of GGF2 . . . read more

Phase III
Alkermes completes patient enrollment . . . read more

Filings
Cornerstone MDS drug gets orphan status . . . read more

Eleison gets orphan status from EC for osteosarcoma treatment . . . read more

FDA Accepts Keryx NDA for Zerenex . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics